Latest news - Johnson & Johnson
Oct 10, 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Press Releases - Johnson & Johnson
Dec 26, 2024 · Explore all Johnson & Johnson published press releases by date and/or topic of news.
News | Johnson & Johnson - Investors
You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, …
Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine ...
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 …
5 facts about Johnson & Johnson’s investigational Janssen COVID …
Jul 30, 2020 · 5 facts about Johnson & Johnson’s investigational Janssen COVID-19 vaccine candidate With its global Phase 3 clinical trial now fully enrolled with approximately 45,000 …
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Johnson & Johnson single-shot vaccine showed strong and long-lasting protection in the real world The largest real-world evidence study for a COVID-19 vaccine reported to …
Media Center - Johnson & Johnson
Read the latest press releases from Johnson & Johnson, find our press contacts and see our latest social media posts.
Johnson & Johnson Reports Q3 2024 Results | Johnson & Johnson
Oct 15, 2024 · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. “Johnson & Johnson’s strong results in the …
How Johnson & Johnson is improving access to medicine and …
Nov 19, 2024 · As a healthcare leader, Johnson & Johnson is championing nurses and health workers to support a strong workforce that is equipped to serve patients and improve health …
Icotrokinra delivered an industry-leading combination of …
SPRING HOUSE, Pa., Nov. 18, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced positive topline results from ICONIC-LEAD a, a pivotal Phase 3 investigational …